Global Pulse

分类： health

  • Abu Dhabi becomes global first to administer Itvisma gene therapy

    Abu Dhabi becomes global first to administer Itvisma gene therapy

    Abu Dhabi has achieved a groundbreaking medical milestone by becoming the first global location to administer Itvisma (onasemnogene abeparvovec), an innovative gene therapy treatment for spinal muscular atrophy (SMA). The historic procedure was performed at Sheikh Khalifa Medical City (SKMC), operated by SEHA under PureHealth, with oversight from the Department of Health – Abu Dhabi (DoH).

    This revolutionary single-dose gene therapy, developed by pharmaceutical giant Novartis, received accelerated approval from UAE health authorities on November 25, 2025. The achievement positions the United Arab Emirates as the first country outside the United States to implement this cutting-edge treatment, demonstrating Abu Dhabi’s emerging leadership in advanced medical innovation.

    ITVISMA represents a significant advancement in genetic medicine, specifically designed to address the root genetic cause of SMA in patients aged two years and older with confirmed SMN1 gene mutations. Unlike conventional treatments that require ongoing management, this one-time therapy replaces the missing SMN1 gene to enhance motor function and potentially transform patient outcomes.

    Dr. Noura Khamis Al Ghaithi, Under-Secretary of DoH, emphasized the significance of this achievement: “By administering ITVISMA, we are proud to be among the first to provide this innovative treatment, further reinforcing our role as a leader and accelerator in advanced and innovative healthcare.”

    Bader Al Qubaisi, Chief Executive Officer at SKMC, highlighted the collaborative effort behind this medical breakthrough: “Delivering the world’s first ITVISMA treatment at SKMC is a testament to Abu Dhabi’s integrated healthcare ecosystem under the leadership of the Department of Health – Abu Dhabi.”

    This medical advancement signals a new era for regional healthcare accessibility, positioning Abu Dhabi as a emerging destination for cutting-edge medical treatments and establishing the UAE as a significant player in the global healthcare innovation landscape.

  • Seen more mosquitoes? UAE authority issues tips to prevent disease risk

    Seen more mosquitoes? UAE authority issues tips to prevent disease risk

    The United Arab Emirates’ Ministry of Health and Prevention has issued an urgent advisory concerning increased mosquito activity during the cooler winter months. As residents increasingly engage in outdoor activities, health authorities warn that rising mosquito populations significantly elevate the risk of mosquito-borne diseases, making effective control measures essential for public health protection.

    Health officials have identified stagnant water sources as primary breeding grounds for mosquitoes, which thrive in humid conditions and can rapidly multiply following rainfall events. These insects, classified by Dubai Municipality as ‘public health pests,’ are known vectors for serious illnesses including dengue fever, with typical lifespans ranging from two to four weeks depending on environmental conditions.

    The ministry has implemented a multi-faceted approach to address the situation, urging residents to promptly report both mosquito sightings and potential breeding sites to authorities through the dedicated hotline 8003050. Medical experts advise against scratching mosquito bites and recommend applying ice packs for approximately ten minutes to alleviate itching, supplemented by anti-itch or antihistamine creams when necessary.

    Comprehensive prevention strategies include installing window and door flyscreens, utilizing chemical insecticides according to safety guidelines, and employing UV insect traps as alternative solutions for households with children or pets. Dubai residents can access complimentary pest control services through municipal channels including the call center, official application, or website chatbot.

    The ministry emphasizes the critical importance of engaging only authorized pest control providers, cautioning that improper pesticide application by unlicensed entities poses significant health and safety risks. Individuals experiencing symptoms such as high fever, severe headaches, or persistent body pain following mosquito bites should seek immediate medical attention, as these may indicate mosquito-borne illnesses requiring professional treatment.

  • Noisy chewing affecting ability to work? Misophonia is a daily battle, UAE doctors warn

    Noisy chewing affecting ability to work? Misophonia is a daily battle, UAE doctors warn

    Medical specialists across the United Arab Emirates are bringing attention to misophonia, a neurological condition characterized by extreme sensitivity to specific everyday sounds, warning that it represents more than mere irritation but a legitimate clinical disorder with significant consequences. Unlike typical annoyance, misophonia triggers intense emotional and physiological responses that can severely disrupt cognitive functions and social interactions.

    According to recent research cited by UAE healthcare professionals, including a PubMed-listed study titled ‘The Effect of Misophonia on Cognitive and Social Judgments,’ trigger sounds such as chewing, pen-clicking, or loud breathing can interrupt attention, impair memory recall, cloud social judgment, and disrupt overall cognitive processing. This creates substantial challenges in educational settings, open-plan offices, and family environments where these sounds are commonplace.

    Dr. Lekha Kapoor, Consultant ENT at Medcare Hospital Sharjah, explains the diagnostic process: ‘We first conduct comprehensive ENT evaluations to rule out auditory issues, then utilize the Amsterdam Misophonia Questionnaire to assess severity—ranging from mild to extreme cases.’ She notes that patients often present confused and distressed, unaware their experiences constitute a recognized medical condition.

    The psychological toll can be severe, with many patients experiencing overlapping anxiety, depression, and heightened stress. In extreme cases, the condition has been associated with suicidal tendencies due to the profound disruption to daily functioning and social relationships.

    Despite its significant impact, awareness remains limited in the UAE compared to Western nations. Dr. Amal Atwa Ibrahim, Consultant Psychiatrist at NMC Specialty Hospital, emphasizes that professional intervention—particularly cognitive behavioral therapy (CBT), emotional regulation strategies, and practical tools like noise-cancelling headphones—can substantially improve quality of life for those affected.

  • Bascom Palmer Eye Institute launches operations in Abu Dhabi

    Bascom Palmer Eye Institute launches operations in Abu Dhabi

    Abu Dhabi has significantly enhanced its specialized healthcare infrastructure with the official inauguration of Bascom Palmer Eye Institute, marking the first international expansion of America’s top-ranked ophthalmology facility. The state-of-the-art medical center, now fully operational in Mohamed Bin Zayed City, represents a major advancement in regional eye care accessibility.

    The 70,000-square-foot standalone facility commenced operations following coordinated efforts between the Department of Health – Abu Dhabi (DoH) and the University of Miami Health System. The launch ceremony featured an exclusive tour led by Dr. Noura Khamis Al Ghaithi, Undersecretary of DoH, alongside executive directors and institutional CEOs, demonstrating the center’s advanced diagnostic suites, surgical capabilities, and patient-focused workflows.

    Dr. Al Ghaithi emphasized the strategic importance of this development: “This partnership exemplifies our ongoing commitment to delivering superior healthcare services while strengthening clinical excellence and promoting knowledge transfer. It significantly supports Abu Dhabi’s vision for an integrated, innovative healthcare ecosystem that addresses both current and future community needs.”

    The facility offers comprehensive ophthalmological services featuring specialized refractive and laser treatments, with initial clinical priorities focusing on retinal, corneal, oncologic, and pediatric ophthalmology. Medical leadership confirmed that all clinical protocols and technological implementations have been directly adapted from Bascom Palmer’s Miami operations, ensuring identical care standards that earned the institute its #1 ranking in the United States.

    Dr. Dipen J Parekh, CEO of University of Miami Health System, noted the achievement of operational readiness ahead of schedule, highlighting seamless care-pathway transitions from their American network. The center has implemented customized digital platforms and scheduling systems specifically designed for Abu Dhabi’s diverse demographic profile.

    International and GCC patients can access specialized visa support, concierge services, and bundled medical packages including post-procedure recovery options, providing alternatives to long-distance travel for advanced ocular treatments. This initiative substantially reinforces Abu Dhabi’s position as a leading global healthcare destination while expanding regional access to world-class medical expertise.

  • Flu cases fall to moderate level

    Flu cases fall to moderate level

    China has witnessed a significant downturn in influenza activity, with national surveillance data indicating a descent to moderate transmission levels across most regions. According to the latest epidemiological report from the Chinese Center for Disease Control and Prevention, the country’s flu positivity rate among influenza-like illness cases dropped to 41.9% during the week beginning December 15, 2025, marking a substantial decrease from the previous week’s 50.2% rate.

    The epidemiological landscape shows varied regional patterns, with northern, northeastern, southwestern, and northwestern provinces experiencing the most notable improvements. However, eastern, southern, and central regions continue to report elevated flu activity, maintaining high transmission levels despite the overall national decline.

    In parallel developments, educational institutions have reported a dramatic reduction in infection clusters, suggesting effective containment measures in school environments. Meanwhile, respiratory syncytial virus (RSV) has demonstrated an upward trajectory, particularly in northern provinces, indicating a possible epidemiological shift.

    The surveillance data further reveals fluctuating patterns for rhinovirus while confirming that SARS-CoV-2 and other monitored respiratory pathogens remain consistently at low prevalence levels, highlighting the specific nature of the current respiratory disease landscape.

  • A GCC landmark moment: King’s College Hospital London Dubai unveils its new Bahrain clinic

    A GCC landmark moment: King’s College Hospital London Dubai unveils its new Bahrain clinic

    In a significant development for Gulf Cooperation Council healthcare, King’s College Hospital London Dubai has officially launched its new medical facility in Bahrain, marking a strategic expansion of British healthcare standards in the region. The inauguration ceremony, held at Bahrain Specialist Hospital in Manama, brought together senior representatives from Bahrain, the United Arab Emirates, and the United Kingdom, symbolizing a trilateral partnership in medical excellence.

    The event featured distinguished attendees including Alastair Long, British Ambassador to Bahrain, who emphasized the importance of bringing globally recognized healthcare services to Bahraini residents. ‘The arrival of King’s College Hospital represents an exciting advancement for healthcare accessibility in the Kingdom,’ Long remarked. ‘Patients can now experience premium UK medical standards without traveling abroad.’

    Kimberley Pierce, CEO of King’s College Hospital London Dubai, characterized the expansion as a commitment to delivering trusted, consultant-led care to communities throughout the GCC. The new clinic will initially provide services through medical professionals traveling from Dubai, covering multiple specialties for both adult and pediatric patients.

    The operational model ensures that routine consultations and treatments occur locally in Bahrain, while complex procedures will facilitate seamless referrals to the Dubai facility, maintaining continuity of care. The rollout includes planned specialty clinics in neurosciences beginning January, followed by pediatrics, general surgery, liver transplant services, and orthopedics—all adhering to King’s clinical governance protocols.

    This initiative forms part of a broader regional strategy to create integrated healthcare pathways connecting the UAE, Bahrain, and the UK. The collaboration builds upon a knowledge and innovation framework established earlier this year, strengthening medical cooperation and elevating healthcare standards across the Gulf region.

  • How UAE expat whose body shut down at 21 due to Covid now helps others get healthy

    How UAE expat whose body shut down at 21 due to Covid now helps others get healthy

    A young expatriate in the UAE has transformed personal tragedy into professional purpose after COVID-19 triggered a life-altering chronic condition. Liam Kotecha, now 26, has become a beacon of hope for others battling invisible illnesses after his own medical journey reshaped his career path and life perspective.

    In 2020, while studying dentistry in Madrid, Kotecha contracted COVID-19 expecting a routine recovery. Instead, he developed crushing fatigue, widespread pain, and neurological symptoms that defied conventional diagnosis. His body essentially shut down at age 21, leaving him struggling with basic tasks like walking, carrying groceries, and even opening water bottles.

    Over 18 months, Kotecha consulted 17 specialists across Madrid and Dubai, facing repeated dismissals and misdiagnoses before finally receiving confirmation of fibromyalgia—a chronic condition characterized by widespread pain, fatigue, and cognitive difficulties. The diagnosis brought both relief and devastation as he learned the condition was incurable.

    The physical decline forced Kotecha to abandon his dental studies just two years from completion, a heartbreaking decision that felt like ‘grieving a life already planned.’ Beyond academic loss, he struggled with social isolation and the perception of being ‘lazy or dramatic’ as he canceled plans and left gatherings early.

    This personal crisis became a transformational turning point. Kotecha turned to nutrition and naturopathic medicine, implementing gradual changes to his diet, movement, and lifestyle. Through elimination of inflammatory foods, reformer Pilates, yoga, stress reduction, and sleep optimization, he gradually reclaimed functionality—though not complete recovery.

    Now in his final year studying nutritional therapy and naturopathy, Kotecha utilizes social media platforms to educate thousands about chronic illness, post-viral fatigue, and gut health. He participates in wellness talks and community events, connecting particularly with young adults who feel medically dismissed and misunderstood.

    Kotecha emphasizes that healing doesn’t necessarily mean being symptom-free but rather ‘learning how to live well again with patience, support, and the right care.’ While his path diverged dramatically from his original dental aspirations, he has found profound meaning in helping others navigate similar health challenges.

    His story emerges amid growing recognition of post-viral conditions and their impact on young populations, highlighting the need for greater understanding of invisible chronic illnesses within medical systems and broader society.

  • Future Health GCC sets regional standard with AABB accreditation

    Future Health GCC sets regional standard with AABB accreditation

    Future Health GCC Stem Cell Bank has attained the distinguished AABB accreditation, marking a significant advancement in regional healthcare standards. This recognition represents one of the most internationally respected benchmarks for quality assurance, safety protocols, and operational excellence within stem cell processing, preservation, and distribution services.

    The accreditation followed an exhaustive independent evaluation process that scrutinized the organization’s laboratory operations, quality management frameworks, technical competencies, and regulatory adherence. This achievement substantially enhances Future Health GCC’s credibility among families, medical professionals, and research institutions throughout the Gulf region, demonstrating its dedication to maintaining globally established standards.

    Future Health laboratories now possess multiple international certifications including recognition from the Human Tissue Authority, Medicines and Healthcare products Regulatory Agency (MHRA), Swiss Medic, OFSP, and ISO 9001. The addition of AABB accreditation solidifies the facility’s position as one of the region’s most comprehensively accredited stem cell banks, offering unprecedented assurance regarding the long-term security, integrity, and traceability of preserved stem cell specimens.

    Chief Executive Officer Ahmad Alahmad emphasized the accomplishment’s significance: “Securing AABB accreditation constitutes a pivotal milestone for Future Health GCC. Combined with our ISO certifications and GMP-grade laboratory infrastructure, this achievement establishes our facility among the region’s most rigorously accredited stem cell centers, underscoring our steadfast dedication to quality, safety, and scientific excellence for families and healthcare collaborators in regenerative medicine.”

    This latest accreditation complements Future Health GCC’s sophisticated infrastructure, GMP-grade laboratory facilities, and ongoing investments in technological innovation and specialized expertise. These collective strengths support the organization’s enduring mission to advance regenerative medicine and cellular science while consistently surpassing international standards and stakeholder expectations.

    Established in 2005, Future Health GCC manages the UAE’s largest cryogenic stem cell storage facility and maintains cutting-edge, GMP-grade laboratories engineered to support both contemporary and emerging applications in regenerative medicine and cellular therapies. The organization remains committed to expanding its capabilities in alignment with global scientific progress, guided by robust governance protocols, transparency measures, and an enduring commitment to excellence.

  • How Dubai may be only hope for 3-year-old boy born with spinal muscular atrophy

    How Dubai may be only hope for 3-year-old boy born with spinal muscular atrophy

    In a remarkable medical journey, a three-year-old Turkish boy named Hulus has arrived in Dubai with his family seeking groundbreaking gene therapy for Spinal Muscular Atrophy (SMA)—a rare genetic condition that progressively weakens muscles essential for movement, breathing, and swallowing. Left untreated, SMA often proves fatal for infants and can cause severe disability in older children.

    The United Arab Emirates made medical history earlier this year by becoming the second nation worldwide to approve a revolutionary gene therapy treatment for SMA in eligible patients aged two years and above. This medical advancement delivers a functional gene through a one-time surgical procedure to replace the faulty gene responsible for the condition, potentially halting disease progression and significantly improving quality of life.

    Hulus’s father, Mustafa Ser, a chef from Turkey, explained their desperate search for solutions: “We conducted extensive research through social media and connected with other families affected by SMA. Discovering Dubai’s gene therapy program became our beacon of hope.” The family exhausted their life savings and initiated fundraising campaigns to afford the travel and treatment expenses.

    Medcare Royal Speciality Hospital in Dubai is overseeing Hulus’s treatment, facilitating visa arrangements and providing comprehensive medical supervision. According to Dr. Vivek Mundada, Consultant Paediatric Neurologist at the hospital, “This treatment represents a genuine paradigm shift in SMA care. We’re not only discussing saving lives but preserving independence and functionality in older children and adults.”

    The treatment involves a approximately 30-minute surgical procedure under anesthesia, where the gene therapy is administered via spinal injection. Patients require careful monitoring afterward for potential side effects.

    Hulus’s daily life has centered around intensive therapy regimens, including physiotherapy six days weekly and hydrotherapy sessions. His family has adapted their home environment with specialized equipment to support his continuous physical development.

    Despite the promising treatment, Hulus faces lifelong medical monitoring, including regular assessments of liver enzymes, cardiac function, and respiratory health. His educational path will initially require specialized schooling accommodations.

    The family’s journey highlights both the extraordinary medical advancements emerging from the UAE and the ongoing challenges faced by families dealing with rare genetic disorders worldwide.

  • Lifesaving surgery for girl, 5, gives 2nd chance

    Lifesaving surgery for girl, 5, gives 2nd chance

    In a groundbreaking medical achievement, a five-year-old Chinese girl has been given a second chance at life following an unprecedented series of cardiac procedures. Xiaoni, weighing merely 12.2 kilograms and diagnosed with restrictive cardiomyopathy—an exceptionally rare heart condition representing just 2% of cardiomyopathy cases—has successfully recovered after 110 days of intensive treatment involving two high-risk surgeries.

    The medical breakthrough occurred when a collaborative team led by Professor Liu Xiaocheng from TEDA International Cardiovascular Hospital in Tianjin and Professor Mo Xuming from Nanjing Children’s Hospital determined that conventional treatment options were exhausted. Facing end-stage heart failure without available donor hearts, the medical professionals pioneered a dual artificial heart implantation strategy—a procedure never before attempted on a patient of such low body weight.

    Xiaoni’s condition presented extraordinary challenges: her cardiac chambers were significantly undersized even for her age, and she suffered from simultaneous biventricular heart failure requiring biventricular assist device (BiVAD) support. Within a remarkable 13-day timeframe, engineers from Rocor Medical Technology Co collaborated with the medical team to modify their second-generation ‘Rocket Heart’ technology, creating fully magnetically levitated ventricular assist devices specifically tailored to Xiaoni’s anatomical requirements. Each pump weighed a mere 69 grams, with the sewing ring’s outer diameter reduced from 29 millimeters to 22.4 millimeters and its weight dramatically decreased from 6.4 grams to just 1.17 grams.

    Professor Liu highlighted the significance of this achievement, noting that pediatric heart failure devices in developed countries typically rely on bulky extracorporeal pneumatic systems that severely restrict mobility and carry elevated risks of infection and thrombosis. The successful implantation of these miniaturized devices marks China’s entry into the forefront of pediatric artificial heart research and development.

    Following forty days of BiVAD support, Xiaoni received a matching donor heart, enabling a successful transplant that completed her extraordinary medical journey. The achievement has attracted international attention, with several top cardiac centers in the United States, Canada, and Germany expressing interest in clinical collaboration for the innovative technology.

    This medical milestone not only saved a young life but has potentially created new therapeutic avenues for children worldwide suffering from end-stage heart failure, demonstrating how targeted innovation can overcome seemingly insurmountable medical challenges.